Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry.

Aged Aged, 80 and over Coronary Restenosis Female Humans Male Middle Aged Percutaneous Coronary Intervention Prospective Studies Prosthesis Design Registries Retrospective Studies Stents Treatment Outcome

Papyrus coronary aneurysm coronary perforation covered stent outcomes

Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions

ISSN: 1522-726X

Titre abrégé: Catheter Cardiovasc Interv

Pays: United States

ID NLM: 100884139

Informations de publication

Date de publication:
01 11 2021

Historique:

revised: 17 09 2020

received: 08 06 2020

accepted: 02 10 2020

pubmed: 22 10 2020

medline: 15 12 2021

entrez: 21 10 2020

Statut: ppublish

Résumé

To evaluate the rate of procedural success and long-term outcomes of the PK Papyrus (PKP) covered stent (CS). CS are essential in the treatment of coronary artery perforation (CAP). They have also been used to treat coronary artery aneurysms. Limited evidence is available on clinical outcomes with the PKP. This was a multicenter, observational, retrospective, and prospective study. Consecutive patients undergoing intentional PKP implantation in 22 centers in France were included. The primary endpoint was the rate of procedural success. Secondary endpoints included rates of death, myocardial infarction (MI), target lesion revascularization (TLR), in-stent restenosis (ISR), and stent thrombosis (ST). Data from 130 patients were analyzed (mean age 72.5 ± 10.5 years; 71% men). The main indication for PKP was CAP, in 84 patients (65%). Delivery success was achieved in 95% and procedural success in 91%. During the in-hospital stay, 15 patients died (12%) and 7 (5%) presented with ST. Data from 127 patients were available at 19.2 ± 12.8 month follow-up. Thirty-three patients died (26%), 15 (12%) had an MI and 21 (17%) presented with TLR. TLR was due to ISR in 12 patients (9%), 10 had definite ST (8%) and 1 patient for stent under-expansion. The principal indication for PKP was CAP. PKP had high rates of delivery and procedural success. At long-term follow-up, there was a high rate of TLR, mainly due to ISR and ST. These results are consistent with previously reported data in these clinical settings.

Sections du résumé

OBJECTIVES

To evaluate the rate of procedural success and long-term outcomes of the PK Papyrus (PKP) covered stent (CS).

BACKGROUND

CS are essential in the treatment of coronary artery perforation (CAP). They have also been used to treat coronary artery aneurysms. Limited evidence is available on clinical outcomes with the PKP.

METHODS

This was a multicenter, observational, retrospective, and prospective study. Consecutive patients undergoing intentional PKP implantation in 22 centers in France were included. The primary endpoint was the rate of procedural success. Secondary endpoints included rates of death, myocardial infarction (MI), target lesion revascularization (TLR), in-stent restenosis (ISR), and stent thrombosis (ST).

RESULTS

Data from 130 patients were analyzed (mean age 72.5 ± 10.5 years; 71% men). The main indication for PKP was CAP, in 84 patients (65%). Delivery success was achieved in 95% and procedural success in 91%. During the in-hospital stay, 15 patients died (12%) and 7 (5%) presented with ST. Data from 127 patients were available at 19.2 ± 12.8 month follow-up. Thirty-three patients died (26%), 15 (12%) had an MI and 21 (17%) presented with TLR. TLR was due to ISR in 12 patients (9%), 10 had definite ST (8%) and 1 patient for stent under-expansion.

CONCLUSIONS

The principal indication for PKP was CAP. PKP had high rates of delivery and procedural success. At long-term follow-up, there was a high rate of TLR, mainly due to ISR and ST. These results are consistent with previously reported data in these clinical settings.

Identifiants

DOI: 10.1002/ccd.29328 PMID: 33085150

pubmed: 33085150

doi: 10.1002/ccd.29328

doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

Pagination

874-881

Subventions

Organisme : Fundació Privada Daniel Bravo Andreu

Commentaires et corrections

Type : CommentIn

Informations de copyright

Références

Heuser RR, Reynolds GT, Papazoglou C, Diethrich EB. Endoluminal grafting for percutaneous aneurysm exclusion in an aortocoronary saphenous vein graft: the first clinical experience. J Endovasc Surg. 1995;2(1):81-88. https://doi.org/10.1583/1074-6218(1995)002<0081:EGFPAE>2.0.CO;2.

Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts. Circulation. 2003;108(1):37-42.

Briguori C, Nishida T, Anzuini A, Di Mario C, Grube E, Colombo A. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation. 2000;102(25):3028-3031.

Kawamoto H, Tanaka K, Ruparelia N, et al. Short-term and long-term outcomes after polytetrafluoroethylene-covered stent implantation for the treatment of coronary perforation. Am J Cardiol. 2015;116(12):1822-1826. https://doi.org/10.1016/j.amjcard.2015.09.019.

Lattuca B, Schmutz L, Cornillet L, et al. New polyurethane covered stent with low profile for treatment of a large aneurysm after left anterior descending artery stenting: first experience. Int J Cardiol. 2015;201:208-209. https://doi.org/10.1016/j.ijcard.2015.08.036.

Harnek J, James SK, Lagerqvist B. Very long-term outcome of coronary covered stents. A report from the SCAAR registry. EuroIntervention. 2019;20(14):1660-1667. https://doi.org/10.4244/EIJ-D-18-00855.

Hernández-Enríquez M, Lairez O, Campelo-Parada F, et al. Outcomes after use of covered stents to treat coronary artery perforations. Comparison of old and new-generation covered stents. J Interv Cardiol. 2018;31:617-623. https://doi.org/10.1111/joic.12525.

Werner GS, Ahmed WH. Fenestration of a Papyrus PK covered stent to recover the occluded left main bifurcation after sealing a left main perforation during a CTO procedure. Cardiovasc Revasc Med. 2017;18:41-44. https://doi.org/10.1016/j.carrev.2017.03.006.

Kandzari DE, Birkemeyer R. PK Papyrus covered stent: device description and early experience for the treatment of coronary artery perforations. Catheter Cardiovasc Interv. 2019;94(4):564-568. https://doi.org/10.1002/ccd.28306.

Ellis SG, Ajluni S, Arnold AZ, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994;90(6):2725-2730.

Dogu Kilic I, Fabris E, Serdoz R, et al. Coronary covered stents. EuroIntervention. 2016;12(10):1288-1295. https://doi.org/10.4244/EIJV12I10A210.

Erbel R, Eggebrecht H, Roguin A, et al. Prospective, multi-center evaluation of a silicon carbide coated cobalt chromium bare metal stent for percutaneous coronary interventions: two-year results of the ENERGY registry. Cardiovasc Revasc Med. 2014;15:381-387. https://doi.org/10.1016/j.carrev.2014.10.002.

Pilgrim T, Heg D, Roffi M, et al. Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial. Lancet. 2014;384:2111-2122. https://doi.org/10.1016/S0140-6736(14)61038-2.

Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drug-eluting stents: report from the meeting of the circulatory system medical devices advisory panel of the Food and Drug Administration Center for Devices and Radiologic Health. Circulation. 2007;115(17):2352-2357. https://doi.org/10.1161/CIRCULATIONAHA.107.688416.

Swaye PS, Fisher LD, Litwin P, et al. Aneurysmal coronary artery disease. Circulation. 1983;67:134-138. https://doi.org/10.1161/01.CIR.67.1.134.

Núñez-Gil IJ, Terol B, Feltes G, et al. Coronary aneurysms in the acute patient: incidence, characterization and long-term management results. Cardiovasc Revasc Med. 2017;19(5):589-596.

Núñez-Gil IJ, Cerrato E, Bollati M, et al. Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR). Int J Cardiol. 2019;299:49-55. https://doi.org/10.1016/j.ijcard.2019.05.067.

Kawsara A, Núñez Gil IJ, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of Coronary Artery Aneurysms. JACC Cardiovasc Interv. 2018;11(13):1211-1223. https://doi.org/10.1016/j.jcin.2018.02.041.

Hachinohe D, Latib A, Laricchia A, et al. Long-term follow-up of covered stent implantation for various coronary artery diseases. Catheter Cardiovasc Interv. 2019;94:571-577. https://doi.org/10.1002/ccd.28117.

Parikh P, Banerjee K, Sammour Y, et al. Utilization and outcomes of polytetrafluoroethylene covered stents in patients with coronary artery perforation and coronary artery aneurysm: single center 15-year experience. Catheter Cardiovasc Interv. 2019;94(4):555-561. https://doi.org/10.1002/ccd.28448.

Gercken U, Lansky AJ, Buellesfeld L, et al. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results. Catheter Cardiovasc Interv. 2002;56(3):353-360. https://doi.org/10.1002/ccd.10223.

Lee W-C, Hsueh S-K, Fang C-Y, Wu C-J, Hang C-L, Fang H-Y. Clinical outcomes following covered stent for the treatment of coronary artery perforation. J Interv Cardiol. 2016;29(6):569-575. https://doi.org/10.1111/joic.12347.

Lansky AJ, Yang Y, Khan Y, et al. Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. Am J Cardiol. 2006;98(3):370-374. https://doi.org/10.1016/j.amjcard.2006.02.041.

Kufner S, Schacher N, Ferenc M, et al. Outcome after new generation single-layer polytetrafluoroethylene-covered stent implantation for the treatment of coronary artery perforation. Catheter Cardiovasc Interv. 2018;93:912-920. https://doi.org/10.1002/ccd.27979.

Al-Lamee R, Ielasi A, Latib A, et al. Incidence, predictors, management, immediate and long-term outcomes following grade III coronary perforation. JCIN. 2011;4:87-95. https://doi.org/10.1016/j.jcin.2010.08.026.

Guttmann O, Jones D, Gulati A, et al. Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention. EuroIntervention. 2017;13(5):e595-e601. https://doi.org/10.4244/EIJ-D-16-01038.

Nagaraja V, Schwarz K, Moss S, Kwok CS, Gunning M. Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: a systematic review and pooled analysis of data. Catheter Cardiovasc Interv. 2020;96(7):1360-1366. https://doi.org/10.1002/ccd.28646.

Çimci M, Rigamonti F, Varotto L, Hachulla A-L, Roffi M. Exclusion of a coronary aneurysm with a polyurethane covered stent. Archives Turkish Soc Cardiol. 2018;47(7):609-611. https://doi.org/10.5543/tkda.2018.02446.